Dyslipidemias: all 1,101 studies

Page 3 of 12. Open to participants first (161), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate LY3202328 in Overweight Healthy Participants and DyslipidemiaCompletedNCT02714569Phase 1Results posted
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed DyslipidemiaCompletedNCT02662569Phase 3Results posted
• Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified PhytosterolsCompletedNCT02644109Phase 4Results posted
• Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)CompletedNCT02642159Phase 4Results posted
• Bezafibrate Plus Berberine in Mixed DyslipidemiaCompletedNCT02548832Phase 3Results posted
• Bococizumab HIV Evaluation (B-HIVE) StudyTerminatedNCT02524106Phase 3Results posted
• Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)TerminatedNCT02500147Phase 4Results posted
• Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or DyslipidemiaCompletedNCT02458287Phase 3Results posted
• Fenofibrate Treatment in SCICompletedNCT02455336Phase 2/3Results posted
• Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/RitonavirCompletedNCT02442700Phase 4Results posted
• Rosuvastatin Adherence App Study in ChinaCompletedNCT02433288Not applicableResults posted
• Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With DyslipidemiaCompletedNCT02304926Not applicableResults posted
• Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCompletedNCT02275156Phase 1Results posted
• Vascular Lifestyle-Intervention and Screening in PharmacyStatus unknownNCT02223793Not applicableResults posted
• Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk SubjectsCompletedNCT02207634Phase 3Results posted
• Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal AntibodyCompletedNCT02189837Phase 3Results posted
• A Study of Evacetrapib in Participants With Abnormal CholesterolCompletedNCT02168803Phase 1Results posted
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT02100514Phase 3Results posted
• Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid MetabolismCompletedNCT02041104Not applicableResults posted
• Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin TherapyCompletedNCT02030041Phase 3Results posted
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular EventsCompletedNCT01968967Phase 3Results posted
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT01968954Phase 3Results posted
• Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/PenCompletedNCT01879319Phase 3Results posted
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed DyslipidemiaCompletedNCT01854918Phase 3Results posted
• Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/PenCompletedNCT01849497Phase 3Results posted
• Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid ObesityCompletedNCT01806506Not applicableResults posted
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated RiskCompletedNCT01764633Phase 3Results posted
• Effects of Metformin on Hepatic FFA MetabolismCompletedNCT01729156Phase 4Results posted
• The Effect of XueZhiKang on Fatigue：Comparing With SimvastatinCompletedNCT01686451Phase 4Results posted
• A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular DiseaseCompletedNCT01674712Phase 3Results posted
• Change of Fructose to Fat in South AsiansCompletedNCT01562782Not applicableResults posted
• Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed DyslipidemiaCompletedNCT01551173Phase 4Results posted
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With OlanzapineTerminatedNCT01491490Phase 2Results posted
• A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With DyslipidemicCompletedNCT01462877Phase 4Results posted
• Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)CompletedNCT01436253Results posted
• A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaCompletedNCT01435382Phase 1Results posted
• Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed DyslipidemiaCompletedNCT01420549Phase 3Results posted
• A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)CompletedNCT01414192Results posted
• Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)TerminatedNCT01414166Phase 3Results posted
• A Study of LY2484595 in Japanese SubjectsCompletedNCT01375075Phase 2Results posted
• Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With ObesityTerminatedNCT01351753Phase 2Results posted
• A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of StatinsCompletedNCT01350141Phase 2Results posted
• A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of StatinsCompletedNCT01342211Phase 2Results posted
• Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)TerminatedNCT01335997Phase 3Results posted
• A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)CompletedNCT01333436Not applicableResults posted
• Cardiovascular Events Based On Statin Initiation In The ElderlyCompletedNCT01304641Results posted
• A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected SubjectsCompletedNCT01301066Phase 4Results posted
• A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)TerminatedNCT01294683Phase 3Results posted
• Tailored Communication to Reduce Cardiovascular RiskCompletedNCT01286311Not applicableResults posted
• Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)TerminatedNCT01274559Phase 3Results posted
• A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated TriglyceridesCompletedNCT01262638Phase 2Results posted
• Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaCompletedNCT01256476Phase 4Results posted
• Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and LipolysisCompletedNCT01250990Not applicableResults posted
• Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)CompletedNCT01245738Results posted
• Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With HypercholesterolemiaCompletedNCT01243151Phase 1Results posted
• Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With DyslipoproteinemiaTerminatedNCT01239992Phase 4Results posted
• Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)TerminatedNCT01228019Results posted
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With AtorvastatinCompletedNCT01218204Phase 2Results posted
• GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesCompletedNCT01217112Phase 2Results posted
• Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With AtorvastatinCompletedNCT01163851Phase 1Results posted
• A Study of LY2484595 in Patients With High LDL-C or Low HDL-CCompletedNCT01105975Phase 2Results posted
• Study of Trilipix Effects on Lipids and ArteriesTerminatedNCT01025492Phase 4Results posted
• Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol LevelsCompletedNCT00986986Not applicableResults posted
• A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)CompletedNCT00961636Phase 3Results posted
• MK0524A Bioequivalence Study (0524A-059)CompletedNCT00944645Phase 1Results posted
• MK0524B Bioequivalence Study (0524B-070)CompletedNCT00943124Phase 1Results posted
• Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)CompletedNCT00935259Phase 1Results posted
• Fenofibrate Bioequivalence Study (0767-031)CompletedNCT00928694Phase 1Results posted
• Study to Test GSK256073 in Patients With DyslipidemiaCompletedNCT00903617Phase 2Results posted
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on DialysisCompletedNCT00858637Phase 3Results posted
• A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)CompletedNCT00847197Phase 2Results posted
• Effect of Fenofibrate on Sleep Apnea SyndromeTerminatedNCT00816829Phase 2Results posted
• Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and TriglyceridesCompletedNCT00812955Phase 3Results posted
• Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.CompletedNCT00770653Phase 3Results posted
• Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility StudyCompletedNCT00728910Phase 2Results posted
• Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
• Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant SubjectsCompletedNCT00707746Phase 2Results posted
• A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)CompletedNCT00697203Phase 2Results posted
• An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-HypercholesterolemiaCompletedNCT00694109Phase 3Results posted
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCompletedNCT00680017Phase 3Results posted
• An Open-label Extension to Assess the Continued Efficacy of Omacor Plus SimvastatinCompletedNCT00678743Phase 4Results posted
• ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) StudyCompletedNCT00673881Phase 1/2Results posted
• Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol LevelsCompletedNCT00673660Results posted
• 12-Month, Open-Label, Extension Study of LCP-AtorFen in DyslipidemiaCompletedNCT00664859Phase 2/3Results posted
• Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)CompletedNCT00654628Phase 4Results posted
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00639158Phase 3Results posted
• Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus AspirinCompletedNCT00630877Phase 3Results posted
• Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With DyslipidemiaCompletedNCT00626392Phase 3Results posted
• Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00616772Phase 3Results posted
• Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial HypercholesterolemiaCompletedNCT00607373Phase 3Results posted
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and DyslipidaemiaCompletedNCT00542386Phase 3Results posted
• Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels StudyCompletedNCT00540293Phase 4Results posted
• Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in DyslipidemiaCompletedNCT00504829Phase 2Results posted
• A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed DyslipidemiaCompletedNCT00491530Phase 3Results posted
• MK-0524B Lipid Study (MK-0524B-063)CompletedNCT00479882Phase 3Results posted
• Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)CompletedNCT00479388Phase 3Results posted
• Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial HypercholesterolemiaCompletedNCT00477594Phase 2Results posted
• Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 DiabetesCompletedNCT00477204Phase 2Results posted
• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)CompletedNCT00465088Phase 3Results posted
• A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With DyslipidemiaCompletedNCT00463606Phase 3Results posted

← Dyslipidemias overview